French press talk about us

In magazines & social medias

Discover articles in the French press on our lymphoma research ecosystem: LYSA, LYSARC, CALYM!

Le Magazine de la santé on France 5 devoted Wednesday, May 11, 2022, a program on lymphoma.

 

👉 For more details read our dedicated news 

 

Resistant lymphoma: the hope of a new treatment

To treat lymphoma, chemotherapy is widely prescribed as a first-line treatment. But for those that recur, doctors are turning to immunotherapy.

👉 Read more 

 

HEALTH’S BROADCAST MAGAZINE DE LA SANTÉ – DEDICATED TO LYMPHOMAS

VERLEN STUDY: A WORLD FIRST FOR THE NEW LYSA PROTOCOL

LYSA’s Verlen study began on February 10 and it’s a world first

” This one is about looking for lymphoids. That’s to say on cancers of the lymphatic system which make it possible to do the circulation of immune cells in the blood. “

👉 Learn more 

 

Cancer: a new protocol being studied in Saint-Étienne

” I.CHU.SE (formerly ICLN) is one of 15 French and Belgian centres to offer its patients over the age of 80 with diffuse large B-cell lymphomas to participate in a new study to evaluate a combination of immunotherapies.” Ludovic Fouillet – Hematologist

👉 Learn more 

Fight against cancer: what you need to know about the world first at the Saint-Étienne’s hospital

“Since mid-February, a first patient has benefited from Verlen protocol at the Saint-Étienne’s Hospital Centre. This is a world first. We explain you why.”

👉 Learn more 

 

Polarix study: a new treatment which time-tested at Rouen's Henri Becquerel centre


A great advance has just been made concerning lymphomas’ treatment

” A global study, led by Professor Tilly from Rouen’s Becquerel Centre, has discovered a very promising new treatment. ”

👉 Learn more 

 


A Rouen researcher behind a new treatment for aggressive lymphomas

It is a hope of healing for patients with an aggressive form of lymphoma. A new treatment will be available in a few months, which should improve the chances of survival.

👉 Learn more 


Rouen. Treatment of lymphomas: Professor Tilly makes a great discovery

” Professor HervĂ© Tilly, a renowned hematologist working at Rouen’s Becquerel Hospital, led a study which could well bring news changements in the treatment of certain lymphomas.”

👉 Learn more 

 

 

 


Lymphoma: a new treatment which time-tested at Rouen’s Henri Becquerel centre

” Polarix study’s results showed a 27% reduction in the risk of disease worsening or death ”

👉 Learn more 

 

ASTRAZENECA, THE CARNOT CALYM INSTITUTE AND INSERM TRANSFERT FOR INSERM SIGN A FRAMEWORK AGREEMENT FOR R&D COLLABORATION IN LYMPHOMAS

👉 Learn more 

6th LYSA DAYS IN RENNES

HEALTH. REINDEER technologically advanced IN LYMPHOMA TREATMENT AND RESEARCH

Since Thursday and until Saturday September 4th, Rennes’ LES JACOBINS MONASTERY welcomes [more than 500] lymphoma specialists. ] This opportunity [for all these actors] will allow to take stock of innovations, research and patient care. This Breton capital is renowned for hosting such events.

👉 Learn more 

Thierry Lamy, Director of the Clinical Hematology Department at @CHURennes and Professor at @UnivRennes1, explains why #Rennes and the #JACOBINSMONASTERY were selected to host Les Journées du LYSA ! Find the full interview by clicking here http://urlr.me/fn5w4
@LysaLymphoma


6th LYSA DAYS IN RENNES’ at LES JACOBINS MONASTERY FROM THURSDAY SEPTEMBER 2nd TO SATURDAY SEPTEMBER 4th

👉 Learn more 

The ATLAS program in the PACA Tribune, Egora.fr, ONKO+

“With the Atlas Program, public and private players in cancerology unite against lymphoma”.

👉 Know more

La Tribune is a media specialised in economics

“Atlas, a major program to advance lymphoma research”.

👉 Know more

egora.fr is a media specialised in sciences, medicine and research

“Lymphomes – Atlas: an ambitious public/private collaborative research program”.

👉 Know more

Onko.fr is a media specialised in hematology

On french social media

Our new website in the Pharmacy Monitor, ONKO+, RASanté

A website to inform about lymphoma

👉 Know more

The pharmacy monitor

Lymphoma – Launch of the experts-research-lymphoma.org website

👉 Know more

Onko.fr is a media specialised in hematology

Interview with Dr. Florence Broussais, Hematologist and Medical Director at LYSARC

👉 Know more 

My health in Auvergne-RhĂ´ne-Alpes region

The 1000th patient recruited in the REALYSA study

Lyon: An ambitious “real-life” study to accelerate lymphoma research

👉 Know more

 

 

The inauguration of our CENS-ELI building

In January 2020 on the occasion of inauguration de of our building CENS-ELI

👉 Report available on LinkedIn

Preview reportage France3